1. Home
  2. QTRX vs ARCT Comparison

QTRX vs ARCT Comparison

Compare QTRX & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Quanterix Corporation

QTRX

Quanterix Corporation

HOLD

Current Price

$3.03

Market Cap

160.0M

Sector

Industrials

ML Signal

HOLD

Logo Arcturus Therapeutics Holdings Inc.

ARCT

Arcturus Therapeutics Holdings Inc.

HOLD

Current Price

$15.52

Market Cap

163.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
QTRX
ARCT
Founded
2007
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
160.0M
163.4M
IPO Year
2017
2019

Fundamental Metrics

Financial Performance
Metric
QTRX
ARCT
Price
$3.03
$15.52
Analyst Decision
Hold
Buy
Analyst Count
2
10
Target Price
$6.00
$24.11
AVG Volume (30 Days)
847.5K
1.1M
Earning Date
05-06-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
20.00
EPS
N/A
N/A
Revenue
$37,632,000.00
$82,031,000.00
Revenue This Year
$25.49
N/A
Revenue Next Year
$10.04
$12.77
P/E Ratio
N/A
N/A
Revenue Growth
64.52
N/A
52 Week Low
$2.15
$5.50
52 Week High
$8.77
$24.14

Technical Indicators

Market Signals
Indicator
QTRX
ARCT
Relative Strength Index (RSI) 54.47 59.91
Support Level $2.89 $6.47
Resistance Level $3.25 $17.75
Average True Range (ATR) 0.19 1.39
MACD 0.09 -0.23
Stochastic Oscillator 80.49 51.03

Price Performance

Historical Comparison
QTRX
ARCT

About QTRX Quanterix Corporation

Quanterix Corp is a life sciences company accelerating biomarker breakthroughs from discovery to diagnostics using ultra-sensitive translational research and spatial biology instruments, consumables, and services. The company sells proprietary instruments and related consumables to research laboratories, contract research organizations (CROs), academic institutions, and bio-pharmaceutical companies, and provides contract research services and clinical laboratory testing services, including four Laboratory Developed Tests (LDTs), through its Accelerator Laboratory. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, and SP-X Imaging and Analysis System. Geographically, it operates in North America, EMEA, and the Asia Pacific.

About ARCT Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.

Share on Social Networks: